Peter Carr

Artificial intelligence platform, RADR®, aids in the discovery of DNA damaging agent for the ultra-rare cancer Atypical Teratoid Rhabdoid Tumors

W. Reinhold, Y. Pommier, S. Varma, 2022, Frontiers in Drug Discovery.

A machine learning-based gene signature of response to the novel alkylating agent LP-184 distinguishes its potential tumor indications

R. Modali, K. Bhatia, J. Richard, 2021, BMC Bioinform..

GenePattern flow cytometry suite

Jill P. Mesirov, Yu Qian, Richard H. Scheuermann, 2013, Source Code for Biology and Medicine.

A machine learning-based gene signature of response to the novel alkylating agent LP-184 distinguishes its potential tumor indications

Jean-Philippe Richard, Umesh Kathad, Panna Sharma, 2021, BMC Bioinformatics.